| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.9M | -58.7% |
| Cost of Revenue | $1.8M | -93.9% |
| Gross Profit | $2.1M | +110.2% |
| R&D Expense | $95.4M | -32.2% |
| SG&A Expense | $46.4M | -45.6% |
| Operating Income | -$121.5M | +71.0% |
| Pre-tax Income | -$178.4M | +56.6% |
| Income Tax | $0 | — |
| Net Income | -$178.4M | +56.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.9M | -88.3% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $1.4M | -72.9% |
| Inventory | $15.4M | +126.1% |
| Current Assets | $31.4M | -75.0% |
| Total Assets | $77.4M | -55.7% |
| Current Liabilities | $131.3M | +61.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$103.3M | +41.1% |
| Capital Expenditures | $8.9M | -81.4% |
| Investing Cash Flow | $61.1M | +152.1% |
| Financing Cash Flow | $14.0M | +873.0% |
| Free Cash Flow | -$112.1M | +49.7% |
| Total Liabilities |
| $152.9M |
| +65.5% |
| Stockholders' Equity | -$75.4M | -191.7% |